Featured
Urban mouse allergens worsen childhood asthma risks
Drug Approvals Nov 7, 2026
Vaccine News Nov 6, 2026
Clinic Moves Nov 5, 2026
People with disabilities may face higher substance misuse risk due to chronic pain and multiple...
Researchers study synthetic growth hormone stimulator to understand its effects on growth hormone secretion.
Checkpoint immunotherapy may reshape melanoma-involved lymph nodes, reorganizing cell types and altering macrophage behavior, Mayo...
Read our latest Drug Approvals articles.
Urban mouse allergens may worsen childhood asthma symptoms, embedding in household dust and triggering reactions...
Mayo Clinic develops a real-time airborne pathogen detection system that could transform indoor biological threat...
Personalized breast cancer screening guidelines are replacing one-size-fits-all approaches, offering tailored plans based on individual...
GammaTile slows brain tumor regrowth in glioblastoma patients with promising results from the GESTALT trial period.
GammaTile slows brain tumor regrowth in glioblastoma patients with promising results from the GESTALT trial period.
Discover the latest stroke rehabilitation guidelines from American Heart Association for improved recovery outcomes with updated recommendations.
FDA approves Oveporexton (Orzeyful) for Type 1 Narcolepsy, first therapy to restore orexin signaling. Learn how it tackles the root...
FDA Week: New blood test for Alzheimer's disease approved. See how Elecsys pTau217 helps identify amyloid pathology in adults 55...
Botox migraine therapy is gaining attention as it shows relief for migraine and spasticity, providing a targeted alternative to systemic...
FDA approval of Avulux migraine lenses offers an over‑the‑counter solution to reduce photophobia for migraine sufferers aged 12+, complementing existing...
Gene therapy MPS II stalls as the FDA places a clinical hold on RGX-121 after MRI scans revealed spinal abnormalities,...
Factor XIa inhibitors are emerging as a promising antithrombotic option to reduce recurrent strokes, offering better protection than aspirin or...
FDA approves new treatments for brain disorders, including Tourette syndrome, with priority review for ecopipam drug application.
New phase 2 trial finds oral cannabis oil failed to reduce chronic pain in Parkinson patients. Read the latest analysis...